JP2024546431A5 - - Google Patents
Info
- Publication number
- JP2024546431A5 JP2024546431A5 JP2024527671A JP2024527671A JP2024546431A5 JP 2024546431 A5 JP2024546431 A5 JP 2024546431A5 JP 2024527671 A JP2024527671 A JP 2024527671A JP 2024527671 A JP2024527671 A JP 2024527671A JP 2024546431 A5 JP2024546431 A5 JP 2024546431A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- pharmaceutically acceptable
- acceptable salt
- independently
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163278242P | 2021-11-11 | 2021-11-11 | |
| US63/278,242 | 2021-11-11 | ||
| PCT/US2022/049607 WO2023086514A1 (en) | 2021-11-11 | 2022-11-10 | Ionizable cationic lipids for rna delivery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024546431A JP2024546431A (ja) | 2024-12-24 |
| JP2024546431A5 true JP2024546431A5 (cg-RX-API-DMAC10.html) | 2025-12-03 |
Family
ID=86336481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024527671A Pending JP2024546431A (ja) | 2021-11-11 | 2022-11-10 | Rna送達のためのイオン化可能なカチオン性脂質 |
Country Status (13)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10383952B2 (en) | 2016-12-21 | 2019-08-20 | Arcturus Therapeutics, Inc. | Ionizable cationic lipid for RNA delivery |
| US10526284B2 (en) | 2016-12-21 | 2020-01-07 | Arcturus Therapeutics, Inc. | Ionizable cationic lipid for RNA delivery |
| CN116574070B (zh) * | 2023-04-07 | 2025-10-31 | 华南理工大学 | 一种多尾型可电离脂质及其制备方法与应用 |
| WO2024233750A1 (en) * | 2023-05-10 | 2024-11-14 | Arcturus Therapeutics, Inc. | Ionizable cationic lipids for rna delivery |
| EP4719352A1 (en) | 2023-05-31 | 2026-04-08 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| KR20240174509A (ko) * | 2023-06-07 | 2024-12-17 | 포항공과대학교 산학협력단 | 핵산 치료제에 사용되는 기능성 지질 라이브러리를 합성하기 위한 단일 연속 유동 합성 방법 |
| WO2025076113A1 (en) * | 2023-10-05 | 2025-04-10 | Capstan Therapeutics, Inc. | Ionizable cationic lipids with conserved spacing and lipid nanoparticles |
| IL328626A (en) | 2023-12-15 | 2026-07-01 | Capstan Therapeutics Inc | Humanized anti-CD8 antibodies and their uses |
| AU2025217182A1 (en) | 2024-02-02 | 2026-08-06 | Editas Medicine, Inc. | MODIFIED GUIDE RNAs |
| WO2025213138A1 (en) | 2024-04-05 | 2025-10-09 | Editas Medicine, Inc. | Crispr/rna-guided nuclease related methods and compositions for treating primary open angle glaucoma |
| WO2026003582A2 (en) | 2024-06-27 | 2026-01-02 | Axelyf ehf. | Lipids and lipid nanoparticles |
| WO2026102260A1 (en) | 2024-11-08 | 2026-05-15 | Editas Medicine, Inc. | Crispr-related methods and compositions targeting angiopoietin like 3 (angptl3) |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3100718B1 (en) | 2008-01-02 | 2019-11-27 | Arbutus Biopharma Corporation | Improved compositions and methods for the delivery of nucleic acids |
| EP2279254B1 (en) | 2008-04-15 | 2017-07-05 | Protiva Biotherapeutics Inc. | Novel lipid formulations for nucleic acid delivery |
| AU2009303345B2 (en) | 2008-10-09 | 2015-08-20 | Arbutus Biopharma Corporation | Improved amino lipids and methods for the delivery of nucleic acids |
| WO2010048536A2 (en) | 2008-10-23 | 2010-04-29 | Alnylam Pharmaceuticals, Inc. | Processes for preparing lipids |
| EP3699172A3 (en) | 2008-11-10 | 2020-11-18 | Arbutus Biopharma Corporation | Novel lipids and compositions for the delivery of therapeutics |
| EP2391343B1 (en) | 2009-01-29 | 2017-03-01 | Arbutus Biopharma Corporation | Improved lipid formulation for the delivery of nucleic acids |
| CA3042927C (en) | 2009-05-05 | 2022-05-17 | Arbutus Biopharma Corporation | Lipid compositions for the delivery of therapeutic agents |
| KR20220038506A (ko) | 2009-06-10 | 2022-03-28 | 알닐람 파마슈티칼스 인코포레이티드 | 향상된 지질 조성물 |
| EP4481047A3 (en) | 2010-06-03 | 2025-04-16 | Alnylam Pharmaceuticals, Inc. | Biodegradable lipids for the delivery of active agents |
| AU2013355258A1 (en) | 2012-12-07 | 2015-06-11 | Alnylam Pharmaceuticals, Inc. | Improved nucleic acid lipid particle formulations |
| CN110003066B (zh) | 2013-11-18 | 2021-09-03 | 阿克丘勒斯治疗公司 | 用于rna递送的可电离的阳离子脂质 |
| DK3221293T3 (da) | 2014-11-18 | 2023-04-03 | Arcturus Therapeutics Inc | Ioniserbar kationisk lipid til RNA-afgivelse |
| US9834510B2 (en) | 2015-12-30 | 2017-12-05 | Arcturus Therapeutics, Inc. | Aromatic ionizable cationic lipid |
| US10526284B2 (en) | 2016-12-21 | 2020-01-07 | Arcturus Therapeutics, Inc. | Ionizable cationic lipid for RNA delivery |
| US10383952B2 (en) | 2016-12-21 | 2019-08-20 | Arcturus Therapeutics, Inc. | Ionizable cationic lipid for RNA delivery |
| US10227302B2 (en) | 2017-02-09 | 2019-03-12 | Arcturus Therapeutics, Inc. | Ionizable cationic lipid for RNA delivery |
| WO2019191780A1 (en) | 2018-03-30 | 2019-10-03 | Arcturus Therapeutics, Inc. | Lipid particles for nucleic acid delivery |
| EP3942050A4 (en) | 2019-03-19 | 2023-02-22 | Arcturus Therapeutics, Inc. | PROCEDURE FOR THE PRODUCTION OF LIPID-COATED RNA NANOPARTICLES |
| JP7562995B2 (ja) | 2020-06-10 | 2024-10-08 | 大日本印刷株式会社 | 重合性液晶組成物、重合体、位相差フィルム及びその製造方法、転写用積層体、光学部材及びその製造方法、並びに表示装置 |
-
2022
- 2022-11-10 JP JP2024527671A patent/JP2024546431A/ja active Pending
- 2022-11-10 IL IL312732A patent/IL312732A/en unknown
- 2022-11-10 EP EP22893632.4A patent/EP4430026A4/en active Pending
- 2022-11-10 CA CA3237904A patent/CA3237904A1/en active Pending
- 2022-11-10 TW TW111143004A patent/TW202337498A/zh unknown
- 2022-11-10 AU AU2022387111A patent/AU2022387111A1/en active Pending
- 2022-11-10 CN CN202280086428.5A patent/CN118451059A/zh active Pending
- 2022-11-10 WO PCT/US2022/049607 patent/WO2023086514A1/en not_active Ceased
- 2022-11-10 KR KR1020247019290A patent/KR20240128677A/ko active Pending
- 2022-11-10 US US17/985,045 patent/US20230295081A1/en active Pending
- 2022-11-10 MX MX2024005714A patent/MX2024005714A/es unknown
- 2022-11-11 UY UY0001040016A patent/UY40016A/es unknown
- 2022-11-11 AR ARP220103119A patent/AR127659A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024518375A5 (cg-RX-API-DMAC10.html) | ||
| CN110522918B (zh) | 靶向元件及其制备方法和运用 | |
| US8192753B2 (en) | pH-sensitive cationic lipids, and liposomes and nanocapsules containing the same | |
| JP5420507B2 (ja) | 薬理活性のある化合物の細胞内送達のためのカチオン脂質として有用な、l−カルニチンまたはアルカノイルl−カルニチンのエステル | |
| US5830430A (en) | Cationic lipids and the use thereof | |
| CN112826808B (zh) | 一种环二核苷酸或其类似物的中性/阳离子混合脂材纳米制剂及其应用 | |
| JP2017536092A5 (cg-RX-API-DMAC10.html) | ||
| JP2001502299A (ja) | リポソーム | |
| CN115867318A (zh) | 一种脂质纳米颗粒 | |
| JP7832717B2 (ja) | 硫化物を含むイオン化可能な脂質、及びこれを含む脂質ナノ粒子 | |
| CN118001254B (zh) | 靶向抗原呈递细胞的脂质组合物及其应用 | |
| CN104983716A (zh) | 肿瘤细胞膜/核膜双靶向肿瘤纳米药物缓释系统及其制备与应用 | |
| WO2025200517A1 (zh) | 一种用于核酸递送的脂质材料及其用途 | |
| US20240016940A1 (en) | Long-acting and long-circulating delivery vehicles | |
| CN109550057B (zh) | 主动靶向型基因递送纳米粒及其制备方法和应用 | |
| US11260068B2 (en) | Long-circulating liposome modified with c(RGD-ACP-K) | |
| US12396949B2 (en) | Technology for improving properties of lipid nanoparticles using lipids in which cis-unsaturated bonds are substituted with a silicon atom | |
| JP2003529550A (ja) | リポソーム封入されたdna経口ワクチン | |
| WO2026052844A1 (en) | 3-component lipid nanoparticle compositions, uses, and manufacturing methods thereof | |
| BR102025005957A2 (pt) | Composição lipídica, uso de uma composição lipídica, composição, método de preparação de uma composição para a administração de um agente terapêutico e/ou profilático às células que apresentam antígenos em órgãos alvo e uso | |
| HK40060954A (en) | Lipid nanoparticle | |
| WO2023024511A1 (zh) | 新型阳离子脂质化合物(一) | |
| CN119818705A (zh) | 一种mRNA组合物及其应用 | |
| AU2024342596A1 (en) | Material for local drug delivery, and use thereof | |
| CN121045013A (zh) | 一种可电离阳离子脂质化合物及其制备方法和应用 |